États-Unis · Plateformes & données · MarketBeat

Milestone Pharmaceuticals (NASDAQ:MIST) Stock Rating Upgraded by Wall Street Zen

Publié par MarketBeat · États-Unis il y a 14 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Wall Street Zen raised shares of Milestone Pharmaceuticals from a "strong sell" rating to a "sell" rating in a report on Saturday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than SpaceX 5 Years From Now

ArrowMark Financial declares $0.15 dividend

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Trump Reportedly Plans To Not Raise Nvidia Spy Issue During China Trip — Elon Musk To Accompany US President

Planning to Claim Social Security at 62? Here Are 3 Critical Questions to Ask Yourself First

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker